San Carlos Medical Hospital Matrid The first unit has created Immune to hematological cancer It has it Place And inside EuropaCan change the paradigm of administration with a new attitude CancerThanks to the study of artificial intelligence and immune disorders.
The immune system is the changes in the immune system The appearance of infections often Regular, compromises the ability to properly control the disease, so they play an important role in cancer.
It is estimated that the deaths of cancer patients are associated with 25% to 50% of infections, and at least 80% of their procedure can overcome at least one severe infection.
With the method of artificial intelligence that created the unit, this is Reaches 91.8% accuracyThis is aimed at diagnosing immune deficiency at the risk of infections by running a customized medicine to prevent the infections and recurrence or progression of cancer, to achieve the best results in the risk of infection.
Sylvia Sanchez-Raman, president of the hospital’s immune system, explained that the use of artificial intelligence method to detect primary immune disorders would allow customized medicine to be customized Early immune disorders detection In patients with hematological cancer, it can be expanded to other types of cancer in the future.
Analysis of 37 high -quality variables by clinical and immune system by clinical and immune deficiency, as published in the medical immune journal.
Selena Penavende, president of the hospital’s Hematology Service, illustrates the importance of a variety of cooperation, and it has raised approximately They will attend two hundred patients per year.
Another study promoted by this pioneer unit, and published in the magazine borders in the immune system, reveals that antibodies, such as kamaglopulins to prevent infections, reveal that staying in intensive care units from 2.7 to zero days to prevent the reducing fourteen hospitals from reducing the days of fourteen hospitalization to prevent infections. Medical leave 124 to 61 days And the cost of drugs is estimated at 5,000 euros per patient and more than 5,000 per year.
